Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
QMS MedicalQ4 FY26Healthcare Equipment & Supplies
Home/Stocks/QMS Medical/Q4 FY26

QMS Medical Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹146P/E: 26.7Market Cap: ₹287 CrSector: Healthcare Equipment & Supplies

Management growth scorecard

Revenue

Category 2

Margin

Category 2

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • →Target to increase revenue from camps from INR13 crores in FY26 to approximately INR18-20 crores in FY27.
  • →Aim to double revenue from the services segment (camps and patient service programs) from around INR50 crores in FY26 to INR100 crores.
  • →Overall revenue guidance for FY27 remains around INR216 crores.
  • →Product segment expected to grow at 10-15% annually.
  • →Services segment growth driven by new contracts, especially with GLP-1 drug patient engagement programs.
  • →Plan to expand number of camps (32,380 conducted in FY26), though not necessarily doubling camp count next year.
  • →Employee hiring targeted around 1,200 for patient service programs to support revenue growth.
  • →EBITDA margin improvement expected with stabilized investments in people, technology, and infrastructure.

Margin guidance

Category 2
  • →QMS Medical Allied Services targets to increase service revenue from INR 50 crores in FY26 to around INR 100 crores by FY27, mainly driven by patient service programs and camps.
  • →Revenue from camps is expected to grow from approx. INR 13 crores in FY26 to INR 18-20 crores in FY27.
  • →The company aims to maintain EBITDA margins at around 18-19% in FY27, with service segment margins at approximately 25% EBITDA and product segment margins at 10-12% EBITDA.
  • →Revenue growth guidance for FY27 remains INR 216 crores, in line with earlier guidance.
  • →Profitability is expected to improve as investments in people, technology, and infrastructure (front-loaded in FY26) begin to yield returns.
  • →Margins compressed in FY26 due to investments for new patient service programs; growth in FY27 expected to reflect a recovery.
  • →EPS growth to follow overall revenue and margin growth, driven by scaling service revenues and contract-backed patient programs.

3 more insights locked — sign up free to unlock

Fundraise plans

The transcript provided in the PDF does not mention any current or future fundraising plans through debt or equity for QMS Medical Allied Services Limited. Key points related to financials focus on revenue growth, investments in people and technology, and operational performance, but no specific discussion on fundraising activities, debt issuance, or equity offerings is mentioned. The company emphasizes growth in service segments and investments front-loaded for future revenue but has not disclosed plans for raising capital via debt or equity during the conference.

Order book

Yes
  • →The company experienced order delays in Q3 and Q4 FY26, primarily on the product segment, due to supply chain and shipping disruptions.
  • →Some March orders were pushed into April and May.
  • →Management expects smoother order flow and positive growth in Q1 and Q2 FY27 compared to the previous year.
  • →No specific quantitative order book or pending orders value was disclosed in the transcript.
  • →Confidence expressed in improving the supply-side challenges moving forward.

Capex plans

Yes
  • →The company is making significant investments in its service segment, focusing on people, infrastructure, and technology to double service revenue in FY26-27.
  • →Investments include hiring new employees (targeting 1,200 hires, with 800-850 already onboarded as of May) for patient service programs.
  • →Capital is being allocated to software development and data compliance systems to meet DPDP Act requirements and enhance service capabilities.
  • →These investments involve intangible assets such as people and custom software, which are expensed currently rather than capitalized.
  • →Equipment for camp employees is a fixed cost (INR 20-25 lakh worth per employee) to support the expansive network covering 5,000 pin codes.
  • →No explicit mention of large-scale traditional capex or strategic acquisitions; emphasis is on building scalable business infrastructure and service capabilities.

How does QMS Medical rank vs peers in Healthcare Equipment & Supplies?

Pro feature
1QMS Medical
Rev 2Mar 2
2Healthcare Equipment & Supplies Company A
Rev 1Mar 2
3Healthcare Equipment & Supplies Company B
Rev 2Mar 1
4Healthcare Equipment & Supplies Company C
Rev 2Mar 3

See full Healthcare Equipment & Supplies sector rankings

How does QMS Medical rank in Healthcare Equipment & Supplies?

Compare QMS Medical against every Healthcare Equipment & Supplies company (Q4 FY26) on revenue, margins and earnings-call signals.

View Healthcare Equipment & Supplies leaderboard →

Related research

Other quarters — QMS Medical

Q2 FY26Q1 FY26Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24

Healthcare Equipment & Supplies peers

Fischer Medical · Q2 FY26Poly Medicure · Q1 FY27Prevest Denpro Ltd · Q1 FY27Tarsons Products · Q1 FY27Vaidya Sane · Q2 FY26
QMS Medical full stock analysisHealthcare Equipment & Supplies sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What QMS Medical's management said in earlier quarters

  • Q2 FY26 earnings call analysis →
  • Q1 FY26 earnings call analysis →

Others in Healthcare Equipment & Supplies this season

  • Prevest Denpro Ltd (Q1 FY27)

    Digital dentistry revenue, especially 3D printing resins, grew 40% this year; 3D printer sales rose by 162%, indicating strong growth potential, with plans for…

  • Vasa Denticity Ltd (Q1 FY27)

    Average order value increased by about 27% largely due to higher ticket-size products; order volume growth was around 8% (Page 6). Key concall takeaways from…

  • Poly Medicure (Q1 FY27)

    Europe and Southeast Asia markets are key growth drivers currently, with Europe showing 17%+ growth in Q1. Key concall takeaways from Poly Medicure's Q1 FY27…

  • Tarsons Products (Q1 FY27)

    Cash profitability grew 18% YoY in Q1 FY’27, showing underlying strength; profits remain moderate in FY’27 due to higher depreciation and interest but will…

Compare:vs Poly Medicurevs Fischer Medicalvs Tarsons Products